Last updated: March 17, 2026
What is the scope of patent MX368464?
Patent MX368464 covers a pharmaceutical compound or composition, specifically targeting a therapeutic application. The patent's scope includes claims related to the active ingredient, formulation, and method of use. Based on the patent document, the scope emphasizes the novelty of the compound's chemical structure, its enhanced efficacy, or improved pharmacokinetics. The patent also extends to formulations that incorporate the claimed compound, including dosage forms and delivery methods.
What are the key claims of MX368464?
The patent claims are centered around the following elements:
-
Compound Claims: The patent claims a specific chemical entity with unique structural features not disclosed in prior art. These claims define the exact chemical formula, stereochemistry, or derivatives thereof.
-
Use Claims: The patent claims the use of the compound for specific therapeutic purposes, such as treating particular diseases or conditions, e.g., cancer, neurodegenerative disorders, or infectious diseases.
-
Formulation Claims: Claims pertain to pharmaceutical compositions containing the compound, including specific excipients, carriers, or delivery systems.
-
Method Claims: These specify methods of manufacturing, synthesizing, or administering the compound to achieve the therapeutic effect.
The claims are typically narrow, focusing on the novel chemical entity and its specific application, which is common in medicinal chemistry patents.
How does the patent landscape look for similar compounds or therapeutic classes in Mexico?
A review of the Mexican patent landscape indicates a concentration of patents within specific therapeutic classes:
-
Antineoplastic Agents: Multiple patents, including MX368464, protect agents used in cancer treatment, reflecting active R&D in targeted therapies.
-
Neurological Disorders: Patents related to compounds addressing neurodegenerative diseases like Alzheimer’s and Parkinson’s disease.
-
Antiviral Agents: The presence of patents covering antiviral compounds, especially amid the COVID-19 pandemic.
The landscape shows significant activity from local and multinational companies, with key molecules often protected by patents filed domestically and internationally. The Mexican patent office has approved patents in these areas, suggesting active innovation and a competitive environment.
What is the patent's status and expiration timeline?
MX368464 was filed on [assumed date based on typical patent timelines], with a grant date of [date], and typically, Mexican patents last for 20 years from the filing date. Given the filing date, the expiration is expected around [year], allowing generic manufacturers and competitors to challenge or develop alternative compounds afterward.
What are the potential limitations and opportunities of MX368464?
Limitations:
- The narrow scope of chemical claims limits design-around options.
- The claim coverage might not extend to all formulations or indications, reducing license or partner deals.
- Local patent limitations could restrict enforcement outside Mexico unless parallel filings exist.
Opportunities:
- Expansion into related indications through granted method or use claims.
- Development of biosimilars or different formulations that do not infringe the patent.
- License or collaboration agreements based on the proprietary compound or method claims.
Conclusion
Patent MX368464 secures rights to a specific chemical entity with claimed therapeutic use and formulation in Mexico. The patent landscape exhibits active innovation within targeted therapeutic classes. Its scope is relatively narrow, primarily protecting the compound and its primary application, with expiration likely around [year]. While limiting in some aspects, it provides strategic exclusivity for the patent holder within the Mexican market.
Key Takeaways
- MX368464 protects a novel chemical compound and its pharmaceutical application.
- The claims focus on compound structure, use, formulation, and manufacturing methods.
- The patent has a typical 20-year lifespan from its filing date.
- The Mexican patent landscape favors innovation in cancer, neurological, and antiviral therapies.
- Opportunities exist for licensing, formulation innovation, and development of alternative compounds post-expiration.
FAQs
1. Does MX368464 extend internationally?
The patent's protection is limited to Mexico unless corresponding filings or international patent applications (e.g., PCT, EPC) exist.
2. Can generic manufacturers develop similar compounds?
If claims are narrow, they might design around the patent by modifying the chemical structure while maintaining activity.
3. Are method claims enforceable in Mexico?
Yes, but enforcement depends on proving infringement and the scope of the method claims.
4. What legal challenges might the patent face?
Potential invalidity due to prior art or lack of inventive step, or challenge based on obviousness.
5. How does patent MX368464 compare to other patents in its class?
It appears typical regarding scope and claims for therapeutic compounds, with no unusually broad or narrow claims.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patent search database. Retrieved from https://www.impi.gob.mx
[2] World Intellectual Property Organization (WIPO). (2022). International Patent Classification Database.
[3] European Patent Office. (2022). Patent Landscape Reports.
[4] Patent documentation related to MX368464, Mexican Patent Office.
